Case number 1:19-cv-12045
BAUSCH HEALTH IRELAND LIMITED et al v. GLENMARK PHARMACEUTICALS LIMITED > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Sep 5, 2019 | N/A | Terminated Case (0) Docket Text: ***Civil Case Terminated. (dmr) |
| Sep 4, 2019 | 9 | Order (2) Docket Text: LETTER ORDER Directing Plaintiffs to take the lead on coordinating the parties' meet and confer session(s), etc. Signed by Magistrate Judge Joel Schneider on 9/4/2019. (rss, ) |
| Sep 4, 2019 | 10 | Notice of Voluntary Dismissal (aty) (2) Docket Text: NOTICE of Voluntary Dismissal by ASSERTIO THERAPEUTICS INC., BAUSCH HEALTH IRELAND LIMITED (DENI, WILLIAM) |
| Sep 3, 2019 | 8 | Order Initial Scheduling Conference (Camden) (6) Docket Text: Order Initial Conference set for 10/16/2019 10:00 AM in Room 2060 before Magistrate Judge Joel Schneider.. Signed by Magistrate Judge Joel Schneider on 9/3/2019. (rss, ) |
| Aug 6, 2019 | 7 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE Returned Executed by BAUSCH HEALTH IRELAND LIMITED, ASSERTIO THERAPEUTICS INC.. GLENMARK PHARMACEUTICALS LIMITED waiver sent on 7/31/2019, answer due 9/30/2019. (DENI, WILLIAM) |
| Jul 16, 2019 | 6 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by J. BRUGH LOWER on behalf of ASSERTIO THERAPEUTICS INC., BAUSCH HEALTH IRELAND LIMITED (LOWER, J.) |
| May 3, 2019 | N/A | Notice of Judicial Preferences (0) Docket Text: Notice of Judicial Preferences. Click here for the Judge's Individual Procedure Requirements. (ssp, ) |
| May 3, 2019 | 4 | Summons Issued (2) Docket Text: SUMMONS ISSUED as to GLENMARK PHARMACEUTICALS LIMITED. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (ssp, ) |
| May 3, 2019 | 5 | AO120 Patent/Trademark Form (1) Docket Text: AO120 Patent Form filed. (ssp, ) |
| May 1, 2019 | N/A | Add and Terminate Judges (0) Docket Text: Judge Renee Marie Bumb and Magistrate Judge Joel Schneider added. (dd, ) |
| May 1, 2019 | 1 | Complaint (13) |
| May 1, 2019 | 1 | Exhibit 1 (10) |
| May 1, 2019 | 1 | Exhibit 2 (13) |
| May 1, 2019 | 1 | Exhibit 3 (15) |
| May 1, 2019 | 1 | Exhibit 4 (40) |
| May 1, 2019 | 1 | Civil Cover Sheet (1) |
| May 1, 2019 | 1 | L. Civ. R. 11.2 Certification (1) |
| May 1, 2019 | 2 | Corporate Disclosure Statement (aty) (1) Docket Text: Corporate Disclosure Statement by BAUSCH HEALTH IRELAND LIMITED identifying Bausch Health Companies Inc. as Corporate Parent.. (DENI, WILLIAM) |
| May 1, 2019 | 3 | Corporate Disclosure Statement (aty) (1) Docket Text: Corporate Disclosure Statement by ASSERTIO THERAPEUTICS INC. identifying BlackRock, Inc. as Corporate Parent.. (DENI, WILLIAM) |
| May 1, 2019 | 1 | Main Document (13) Docket Text: COMPLAINT against GLENMARK PHARMACEUTICALS LIMITED ( Filing and Admin fee $ 400 receipt number 0312-9633488), filed by BAUSCH HEALTH IRELAND LIMITED, ASSERTIO THERAPEUTICS INC.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Civil Cover Sheet, # (6) L. Civ. R. 11.2 Certification)(DENI, WILLIAM) |
| May 1, 2019 | 1 | Complaint* (1) |
